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     A case of cold urticaria in a 38-year-old woman was reported. The urticaria was 
demonstrated to have the following features: 
(i) The urticaria was associated with cryofibrinogenemia 
(ii) The passive transfer test was negative both with the patient's serum and with cryo-
fibrinogen. 
(iii) Whereas orally administered Tavegyl was not effective, Periactin proved to be 
effective in the treatment of the condition.
                   INTRODUCTION 
     One of the varieties of urticaria, called physical urticaria, is caused by physical 
agents, e. g. mechanical stimuli, sunlight, heat and cold.'-') However, its true nature 
and exact pathogenetic mechanism still remain obscure and a matter of controversy.') 
     We experienced recently a case of cold urticaria associated with cryofibrinoge-
nemia, a relatively rare type of cold urticaria. The purpose of this paper is to present 
the case, with a review of pertinent literature.
                   CASE RFPORT 
     About eight years before initial examination, a 38-year-old housewife began to 
develop erythema or wheals associated with itching over the skin areas of the face, neck, 
forearm or the dorsal aspect of the hands, and lower legs or dorsum pedis on exposure to 
cold wind in winter without known precipitating cause. 
These wheals disappeared in about one hour and were not accompanied by headache, 
abdominal pain and fever, nor by Raynaud's phenomenon and hemoglobinuria. She was 
entirely free from wheals during summer.
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 Cold test : (1) Exposure to cold resulted in the development of erythema or wheal with 
itching in 5 to 10 minutes ; (2) placement of a beaker containing iced water on the 
flexor aspect of the forearm was followed by similar skin manifestation. 
 Laboraory findings : Data for the following were normal ; Hemoglobin, urine microscopy 
and analysis for blood glucose, and protein, white blood cell count and differential cell 
count, thrombocyte count, blood coagulation system, IgG, IgM, IgA, GOT, GPT,
cholesterol, and serologic test for syphilis was negative. 
  Investigation of cryoprotein : The cryoprecipitate was 
obtained by cooling heparinized or citrated plasma for 
24 hours at 4°C but negative with serum. (Fig. 1 
right, control plasma ; left, patient's plasma). This 
cryoprecipitate was centrifuged at 5000 rpm for 30 
minutes at 4°C, washed 3 times with PBS and after 
being resolved in a water bath at 37°C, was subjected 
to immunoelectrophoresis. As illustrated in Fig. 2, the 
cryoprecipitate was shown to produce a precipitin line 
with anti-fibrinogen serum but not with anti-whole 
human serum. The content of the cryofibrinogen was 
estimated as the difference between the fibrinogen
Figure. 1.
content of plasma prior to and after cooling at 4°C for 24 hours (as measured by M-Parti-
gen-Fibrinogen). 
Thus, a cryofibrinogen content of 218.5 mg/dl was obtained by subtracting a post-cooling 
fibrinogen content of plasma of 499.1 mg/dl from a pre-cooling value of 717.6 mg/dl. 
Passive transfer test : The patient's serum and cryofibrinogen were injected intradermally
Figure. 2. N.S.; normal serum, p. p.; patient's plasma, Cryo; cryoprecipitate.
into a healthy volunteer, who was then exposed to cold 2, 6 and 24 hours after the injection. 
No erythema nor wheal was not seen in such treatments. 
  Treatment : The oral administration of Tavegyl having an antihistaminic action failed to 
elicit any favorable response. Periactin, which is presumed to possess antikinin actionn 
besides antihistamine and antiserotonin effects, provided adequate control of the cold 
urticaria. However, the patient continued to demonstrate cryofibrinogen during treatment. 
                    DISCUSSION 
     Urticaria has various possible causes. 1,2) Cold urticaria, as indicated by statistics 
of Champion et al. 1), is a relatively common condition in comparison with the physical 
variety of urticaria, such as solar urticaria. However, its pathogenetic mechanism still 
remains obscure in many respects. 
     Although there is as yet no established classification of cold urticaria,"4) the 
classification by Lobitz3) has been frequently utilized (Tabl 1). Houser, 5) in his study of 
90 reported cases, stated that of this series, 5% were congenital and familial, 67% were 
acquired and essential, while of the remaining 28%, 20%, 3% and 5%, respectively, 
were due to cryoglobulin, cryofibrinogen and cold hemolysin. 
     Congenital familial cold urticaria has onset at birth and is accompanied with general 
symptoms such as chills, fever, headache and arthralgia. It is a rare condition which is 
inherited as a dominant abnormality and exhibits a negative P-K reaction .6,7) 
     The acquired essential variety accounts for the bulk of cold urticaria cases. One -
third of patients with this disorder has a past or family history of atopic disease, while 
approximately one half gives a positive P-K reaction. In cases reported by Houser,5) 
Furukawa8) and Kaplan9) the P-K factor was identified as IgE, while in those of 
Wanderer10) and Ohkudoll> IgM was found responsible. Some allergic mechanism is 
thus likely to be involved in the development of cold urticaria in these cases. 
     Cold urticaria associated with cryoglobulinemia has been reported so far by a few
Table. 1. 
(1) Cryoglobulinemia 
    (i) Essential Cryoglobulinemia 
    (ii) Symptomatic Cryoglobulinemia 
(2) Paroxysmal Cold Hemoglobulinuria 
    (i) Syphilitic Paroxysmal Cold Hemoglobulinuria 
    (ii) Non-syphilitic Paroxysmal Cold Hemoglobulinuria 
(3) Cold Hemagglutination 
    (i) Essential Cold Hemagglutination 
    (ii) Secondary Cold Hemagglutination 
(4) Essential Cold Urticaria 
    (i) Congenital Familial Essential Cold Urticaria 
    (ii) Acquired Essential Cold Urticaria
authors in this country, 12)13) but the implication of cryoglobulin in this disease state still 
is not known. 11)14) 
     Paroxysmal cold hemoglobinuria and cold agglutininemia, conditions which are 
characterized by the respective presence of Donath-Landsteiner antibody and cold haema-
gglutinin in the serum, give rise to hemolytic manifestations and Raynaud's phenomenon 
on exposure to cold and may also be accompanied by cold urticaria. 
      Our present case was negative for P-K reaction and free from cryoglobulin and 
hemoglobinuria and may hence be considered to represent cold urticaria due to cryofibri-
nogen, a type of rare occurrence. 
     As can be seen in Table 2, cryofibrinogenemia may be roughly divided into 2 types, 
i.e. primary or idiopathic, in which a primary disease cannot be detected by any available 
means, and secondary which is often associated with malignant neoplasms or auto-immune 
diseases. Most of cases are of the latter type.") 
     The mechanism of development of cryofibrinogenemia is controversial. Thus, some 
insist that cryofibrinogen is a combination product of fibrinogen denatured by a primary 
disease process such as malignant tumors and other blood proteins,") others surmise that 
cryofibrinogen might represent an intermediate product formed during the conversion of 
fibrinogen to fibrin in the presence of increased blood coagulability (with resultant genera-
tion of thrombin)") or a product of an antigen-antibody reaction.18) 
     Major clinical symptoms of cryfibrinogenemia are thrombosis, hemorrhage, hyper-
sensitivity to cold and ulcer or gangrene.") Reported dermatologic manifestations include 
cutaneous bleeding, l5)10)cold urticaria, 4) 16) Raynaud's phenomenon, 11)10) cutis marmorata,19) 
numbness or pain in the extremities, 19)21) leg ulcer 21) and pyoderma gangrenosum.24)25)Among 
reported cases of cold urticaria, one of Dagenais16) was of primary cryofibrinogenemia 
and presented with recurrent nasal bleeding, headache and facial palsy besides cold 
urticaria. Cryofibrinogen in this case was demonstrated to have thrombin inhibitory effect. 
Miller's case 4) too, was of primary cryofibrinogenemia with concurrent hay fever; 
in addition to cold urticaria, there were pain and swelling of hand joints occurring several 
days before menstrual flow. The author stated that whereas antihistaminics all proved of
  Tablet- 2. Demonstration of Cryofibrinogenemia 
I. Primary or idiopathic (with or without Raynaud's phenomenon) : 
     Digital gangrene, Cerebrovascular accident. 
II. Secodary to : 
   (a) Neoplasma
         Carcinoma of the buccal mucosa, Liver, Kidney, Prostate, Lung., 
         Lymphoma, Multiple myeloma,, Myelo-proliferative disease., Teratoma., 
   (b) Collagen disease 
         Rheumatic fever., SLE., 
   (c) Others 
         Ulcerative colitis., Pueumonia., Bronchiolitis., Myocardiar 
         infarction., Foreign body inflammation., Hyperthyroidism., 
          Livercirrhosis. , etc.
no therapeutic value, oral steroids were beneficial. Also in our own case the diagnosis of 
cold urticaria associated with primary cryofibrinogenemia was made after numerous attempts 
to detect a primary disease had proven unsuccessful. To be noted is the fact that the 
patient had no concurrent symptoms of thrombosis and hemorrhage nor did she exhibit 
any abnormalities in the clotting system. 
     The pathogenesis of this cold urticaria occurring in association with cryofibrinoge-
nemia is entirely unknown at the present time partly because cases available are extremely 
few and, moreoever, cold urticaria is absent in many of cryofibrinogenemia and also 
partly because of a lack of sufficient knowledge of cryofibrinogen. A study of additional 
cases will be necessary before the question of whether or not cryofibrinogenemia observed 
in these cases had any significance for urticaria or it represented merely a fortuitous 
complication of essential cold urticaria can be correctly answered. 
     There are a variety of substances that are supposed to act as a chemical mediator 
in the production of urticaria.26) Of particular interest is the problem of what substance or 
substances play such a role in the development of cold urticaria. 
In this connection, Rose") and Henderson28) noted an elevation of blood histamine 
level following exposure to cold. More recently, Kaplan9) investigated 6 cases of essen-
tial cold urticaria and stated that the chemical mediator might presumably be histamine. 
Juhlin29) surmised the liberation of histamine from mast cells and basophils. Delaus3o), 
on the other hand, concluded that exposure to cold is followed by release of kinin but not 
of histamine from his study of 11 cases. A statement to the same effect was made by 
Aoyama31) in this country. 
     Thus, some investigators are in favor of the histamine theory, while others speak 
for the kinin theory. However, the facts that whereas antihistaminics produced no con-
sistent effect, cyproheptadine which is thought to have antihistamine, antiserotonin and 
antikinin effects proved of therapeutic benefit32) and also that Periactin (cyproheptadine) 
was effective in the treatment of our present case might provide evidence in support of 
the kinin theory. This issue remains to be settled by further studies. 
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